Chairman of Devyser Diagnostics Mia Arnhult Buys More Stock

Potential Devyser Diagnostics AB (publ) (STO:DVYSR) shareholders may wish to note that the Chairman, Mia Arnhult, recently bought kr1.6m worth of stock, paying kr110 for each share. Although the purchase is not a big one, by either a percentage standpoint or absolute value, it can be seen as a good sign.

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

Devyser Diagnostics Insider Transactions Over The Last Year

Notably, that recent purchase by Mia Arnhult is the biggest insider purchase of Devyser Diagnostics shares that we've seen in the last year. So it's clear an insider wanted to buy, at around the current price, which is kr113. That means they have been optimistic about the company in the past, though they may have changed their mind. If someone buys shares at well below current prices, it's a good sign on balance, but keep in mind they may no longer see value. Happily, the Devyser Diagnostics insider decided to buy shares at close to current prices. Mia Arnhult was the only individual insider to buy during the last year.

Mia Arnhult purchased 21.08k shares over the year. The average price per share was kr109. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

View our latest analysis for Devyser Diagnostics

Devyser Diagnostics is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket.

Does Devyser Diagnostics Boast High Insider Ownership?

Many investors like to check how much of a company is owned by insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. It appears that Devyser Diagnostics insiders own 32% of the company, worth about kr598m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

So What Does This Data Suggest About Devyser Diagnostics Insiders?

The recent insider purchase is heartening. We also take confidence from the longer term picture of insider transactions. But on the other hand, the company made a loss during the last year, which makes us a little cautious. Once you factor in the high insider ownership, it certainly seems like insiders are positive about Devyser Diagnostics. Nice! Therefore, you should definitely take a look at this FREE report showing analyst forecasts for Devyser Diagnostics.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.